2024-511853-23-00CompletedPhase 1
A phase 1/2a study to evaluate the dose, safety, tolerability, and efficacy of an intraperitoneal α-emitting radionuclide therapy (Radspherin®) in subjects with peritoneal carcinomatosis from colorectal carcinoma following hyperthermic intraperitoneal chemotherapy
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Oncoinvent ASA
- Enrollment
- 54
- Locations
- 2
Study Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 65+ years (18-64 Years, 65+ Years)
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Information Desk
Scientific
Oncoinvent ASA
Study Sites (2)
Loading locations...
Similar Trials
Recruiting
Phase 1
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid TumorsNCT07278479Molecular Partners AG138
Recruiting
Phase 1
A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid TumorsBreast CancerLung CancerNCT07274852Sichuan Baili Pharmaceutical Co., Ltd.22
Recruiting
Phase 1
KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell LymphomaDiffuse Large B Cell Lymphoma (DLBCL)NCT07260812TCRx Therapeutics Co.Ltd18
Recruiting
Phase 2
MK-4280 and Pembrolizumab in Hematologic Malignancies2023-503587-17-00Merck Sharp & Dohme LLC35
Completed
Phase 1
A phase Ib study to investigate the safety and effect of BR-0032024-516338-37-00SentryX B.V.6